|
Post by sportsrancho on Sept 8, 2016 16:04:35 GMT -5
Wow, that's a big contribution. Thanks for your efforts. Please let us know once the MNKD rep has spoken with the medical group and what was their impression. thanks ! I will tell you guys all about it as we go along:-) I can't wait till Walt, (Dr.Combs) writes his first script!
|
|
|
Post by MnkdWASmyRtrmntPlan on Sept 8, 2016 17:08:05 GMT -5
Along the lines of getting the story out, has anyone approached NPR about the Mankind story, Afrezza and BP? If not, I think I shall. Can anyone point me to a good and accurate summary of all this because I may not be the best at explaining all that went/is going on. I LOVE it! That would make such a great NPR story. As mentioned by Tayl5, best to wait until the sales pick up and the turn-around gets underway. But, now is probably the time to start getting NPR educated on this story. Sorry, but I wouldn't be any good at that, but I sure wish you the best of luck, minnlearner, or SOMEbody grabs the ball and runs with that. I would sooo love to hear the "Mannkind Story" on NPR. Probably best to start selling the story to Kai Ryssdal and MarketPlace. Sorry, I don't know where to point you to a summary. Maybe someone else does. There are probably a lot of them out there.
|
|
|
Post by nylefty on Sept 8, 2016 17:50:14 GMT -5
Marketplace is not a NPR program; it's an American Public Media show. All the public radio stations that I'm familiar with carry programming from both NPR and APM. which are separate organizations. www.americanpublicmedia.org/ I worked in radio and TV news for many years and agree that the MannKind story will be much more attractive to the media when there's a turnaround, rather than now when the story is 'here's a little biotech company that so far has been a failure, but which some investors think will be successful some day.'
|
|
|
Post by babaoriley on Sept 8, 2016 19:04:45 GMT -5
I think it's a great NPR story as is, not about MNKD, but about Afrezza - almost exclusively about Afrezza. We got guys like Sam and Eric who could be interviewed in person while eating a high carb meal and showing results on a CGM. For an NPR, at this stage, the story is noteworthy for what Afrezza offers so many people. If MNKD makes it in the end, then a piece featuring MNKD, but by that time, I won't care. I just want diabetics to know this stuff exists, and fellow diabetics think the world if it.
|
|
|
Post by gamblerjag on Sept 8, 2016 19:09:37 GMT -5
NY Lefty... that made a lot of sense.... people usually talk about things when the story is unfolding.. not when it's preliminary.
|
|
|
Post by brotherm1 on Sept 8, 2016 20:20:19 GMT -5
I think it's a great NPR story as is, not about MNKD, but about Afrezza - almost exclusively about Afrezza. We got guys like Sam and Eric who could be interviewed in person while eating a high carb meal and showing results on a CGM. For an NPR, at this stage, the story is noteworthy for what Afrezza offers so many people. If MNKD makes it in the end, then a piece featuring MNKD, but by that time, I won't care. I just want diabetics to know this stuff exists, and fellow diabetics think the world if it. I do like that idea. I also heard the documentary could be finished this month. Would PBS perhaps be interested in airing it on television?
|
|
|
Post by nylefty on Sept 8, 2016 20:22:10 GMT -5
I think it's a great NPR story as is, not about MNKD, but about Afrezza - almost exclusively about Afrezza. We got guys like Sam and Eric who could be interviewed in person while eating a high carb meal and showing results on a CGM. For an NPR, at this stage, the story is noteworthy for what Afrezza offers so many people. If MNKD makes it in the end, then a piece featuring MNKD, but by that time, I won't care. I just want diabetics to know this stuff exists, and fellow diabetics think the world if it. NPR and APM aren't in the drug promotion business. To be fair and objective they'd have to balance Sam and Eric with people who had problems with Afrezza and stopped taking it -- and the dismal refill numbers show that there are a lot of such people. They'd also have to interview both doctors who are enthusiastic about Afrezza and docs who think it has yet to prove itself or is too risky. As an investor I desperately want Afrezza to succeed, but as a journalist I don't see much of a story....yet.
|
|
|
Post by minnlearner on Sept 8, 2016 21:02:55 GMT -5
Thanks a million everyone. My idea was that a NPR story about a new and better drug being sat on by BP. Something like that could get the ball rolling in our favor. Also, i thought a look at manipulation of the stock could be an angle. Just thinking' and I admit I just looking in from the outside, waiting with hope.
|
|
|
Post by esstan2001 on Sept 9, 2016 7:28:02 GMT -5
I think it's a great NPR story as is, not about MNKD, but about Afrezza - almost exclusively about Afrezza. We got guys like Sam and Eric who could be interviewed in person while eating a high carb meal and showing results on a CGM. For an NPR, at this stage, the story is noteworthy for what Afrezza offers so many people. If MNKD makes it in the end, then a piece featuring MNKD, but by that time, I won't care. I just want diabetics to know this stuff exists, and fellow diabetics think the world if it. NPR and APM aren't in the drug promotion business. To be fair and objective they'd have to balance Sam and Eric with people who had problems with Afrezza and stopped taking it -- and the dismal refill numbers show that there are a lot of such people. They'd also have to interview both doctors who are enthusiastic about Afrezza and docs who think it has yet to prove itself or is too risky. As an investor I desperately want Afrezza to succeed, but as a journalist I don't see much of a story....yet. Baba- these damn New Yorkers... always having to be such realists. Could tell you lost your cynicism for a moment, and were actually having happy thoughts. Lefty- have to be such a Killjoy? (Apt name for someone that takes people ['s happiness] out...)
|
|
|
Post by mnholdem on Oct 6, 2016 15:37:57 GMT -5
Monday's the big day. The Afrezza sales team comes to Temecula, CA.
|
|
|
Post by promann on Oct 6, 2016 15:41:25 GMT -5
What's happening on Monday there?
|
|
|
Post by mnholdem on Oct 6, 2016 15:45:08 GMT -5
What's happening on Monday there? I suggest that you go to Page 1 of this thread and begin reading. I've decided to label the event "The Big One" for all those who were disappointed that last week's earthquake warning for So California came to naught. Perhaps the diabetes event in Temecula on Monday will be preceded by some tremors on Wall Street on Friday with resumption of the sales trend continuing to show steady growth in sales of Afrezza.
|
|
|
Post by peppy on Oct 6, 2016 15:49:31 GMT -5
What's happening on Monday there? I suggest that you go to Page 1 of this thread and begin reading. sports baby rancho!
|
|
|
Post by kc on Oct 6, 2016 16:09:04 GMT -5
Was at a dinner on Wed evening in Washington, DC and was seated across from a customer of mine who had a Apple watch on and I struck up a conversation with her about the watch. It turns out she is a T1D who learned at age 33 she was diabetic. The reason why she had the apple watch is that it was getting information from her CGM and sending alert to her watch and to her Mother & Husband back in KC. That she also had a pump on . She then raised both sleeves up on her blouse to show me the CGM on the right arm and the pump on the left arm. We stated talking about her situation. She takes Novlog. Never heard of Afrezza and she is active on the local board of the JDRF. So I then started telling her about Afrezza and showing her pictures from last Sunday at the JDRF St. Louis event. She became very excited about and said for me to send here the information so that she could explore it when she gets back home to KC. Now this is a very educated professional in a Health related field and she had never heard of Afrezza. I will follow up with here and some information. She said it was very difficult on in a business situation to take here injections that Afrezza so she was on the pump.
My view is that we are like a ticking time bomb waiting to explode as very few people even know that Afrezza exists. Getting into the Health clinics is so vital and it takes time to hit all the doctors. The rep in STL said that his new prescriptions in his market double every week. so if that is the situation across the country we will see some scaling up before the end of 2016.
|
|
|
Post by victoria on Oct 6, 2016 16:57:58 GMT -5
Posts like Sportsrancho and kc's (and others of course) make this site great.
|
|